3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical attention due to sparse information suggesting unique biological characteristics. Present studies indicate that 3-HPC may possess independent responses on the brain system, possibly contributing to